Syngene International announces plans to add bioconjugation suite for end-to-end Antibody-Drug Conjugates Development
Syngene International Expands Capabilities Syngene International, a global contract research, development and manufacturing organization (CRDMO), announces plans to add a GMP bioconjugatio…